Chemical-electron-transfer-based lipopolyplexes for enhanced siRNA delivery DOI Creative Commons
Fengrong Zhang, Yi Lin,

Miriam Höhn

и другие.

Cell Reports Physical Science, Год журнала: 2023, Номер 4(6), С. 101444 - 101444

Опубликована: Май 31, 2023

Endosomal escape remains a well-known bottleneck for successful small interfering RNA (siRNA) therapeutics. Here, chemical electron transfer (CET)-based self-activatable lipopolyplex is explored producing singlet oxygen (1O2) in endosomes, thereby enhancing siRNA delivery. The simultaneously encapsulates bis(2,4,6-trichlorophenyl) oxalate (TCPO), gold nanoparticles (GNs), and siRNA. GNs are specifically self-activated by the transferred energy between TCPO hydrogen peroxide, which enhanced tumor microenvironment. Enhanced endosomal membrane damage verified using cytosolic fluorescent galectin-8 (Gal8)-mRuby reporter; oxidation of 1O2 facilitates rupture endosomes within 4 h, improving recruitment Gal8 to disrupted up ∼50-fold. This research demonstrates that CET can facilitate nucleic acids from cytosol provides starting point further delivery applications.

Язык: Английский

Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner DOI Creative Commons
Miao Zeng, Wei Zhang, Yisheng Li

и другие.

Biomarker Research, Год журнала: 2024, Номер 12(1)

Опубликована: Март 25, 2024

Abstract Recombinant adenovirus (rAd) regimens, including replication-competent oncolytic (OAV) and replication-deficient adenovirus, have been identified as potential cancer therapeutics. OAV presents advantages such selective replication, efficacy, tumor microenvironment (TME) remodeling. In this perspective, the principles advancements in developing toolkits are reviewed. The burgeoning rAd may dictate efficacy of conventional therapies well immunotherapies, vaccines, synergy with adoptive cell therapy (ACT), TME reshaping. Concurrently, we explored hitchhiking to immune cells or stem cells, highlighting how approach facilitates synergistic interactions between cellular therapeutics at sites. Results from preclinical clinical trials which were infected used address significant oncological challenges, postsurgical residual tissue metastatic tissue. Briefly, can eradicate tumors through various mechanisms, resulting immunogenicity, reprogramming TME, enhancement immunity, effective targeting. context, argue that holds immense for enhancing immunity synergistically improving antitumor effects combination novel immunotherapies.

Язык: Английский

Процитировано

4

Design of nanosystems for melanoma treatment DOI Creative Commons
Asal Farasatkia, Lidia Maeso,

Hamidreza Gharibi

и другие.

International Journal of Pharmaceutics, Год журнала: 2024, Номер unknown, С. 124701 - 124701

Опубликована: Сен. 1, 2024

Язык: Английский

Процитировано

4

A KIF20A-based thermosensitive hydrogel vaccine effectively potentiates immune checkpoint blockade therapy for hepatocellular carcinoma DOI Creative Commons

Xingyang Zhao,

Feichao Xuan,

Zirong Li

и другие.

npj Vaccines, Год журнала: 2025, Номер 10(1)

Опубликована: Янв. 3, 2025

Язык: Английский

Процитировано

0

Versatile PLGA‐Based Drug Delivery Systems for Tumor Immunotherapy DOI Creative Commons

Yishu Wang,

Xiaoming Hu, Jinghui Wang

и другие.

Small Methods, Год журнала: 2025, Номер unknown

Опубликована: Фев. 9, 2025

Tumor immunotherapy, which utilizes the immune system to fight cancer, represents a revolutionary method for cancer treatment. Poly (lactic-co-glycolic acid) (PLGA) copolymer has emerged as promising material tumor immunotherapy due its biocompatibility, biodegradability, and versatility in drug delivery. By tuning size, shape, surface properties of PLGA-based systems, researchers have improved their ability align with requirements diverse modalities. In this review, basic PLGA materials are first introduced further principal forms systems controlled release summarized delivery applications targeted. addition, recent advances use highlighted enhance antitumor responses terms vaccines, immunogenic cell death-mediated responses, microenvironment modulation, combination immunotherapies. Finally, prospects future research clinical translation proposed.

Язык: Английский

Процитировано

0

Self-Assembling protein nanoparticle platform for multivalent antigen delivery in vaccine development DOI

Hao Wu,

Ruiqi Weng,

Jiaxuan Li

и другие.

International Journal of Pharmaceutics, Год журнала: 2025, Номер unknown, С. 125597 - 125597

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Construction of a tumour-Targeting platform on adenovirus surface based on biotin-streptavidin and polyphenylene dendron corona DOI
Longjie Li, Yuhua Tang, Shuangshuang Wang

и другие.

Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 162929 - 162929

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Cancer cell membrane proteins-encapsulated nanovaccine enhances cancer immunotherapy and prevention by provoking antigen-specific cellular immunity via the dendritic cell-targeted delivery DOI
Xingyu Luo, Xiaolu Chen,

Rongying Ma

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 481, С. 148611 - 148611

Опубликована: Янв. 6, 2024

Язык: Английский

Процитировано

3

Dendrimers as drug delivery systems for oncotherapy: Current status of promising applications DOI

S. SUEYOSHI,

João Vitor Silva, Felipe Guizze

и другие.

International Journal of Pharmaceutics, Год журнала: 2024, Номер 663, С. 124573 - 124573

Опубликована: Авг. 10, 2024

Язык: Английский

Процитировано

3

Novel targets and improved immunotherapeutic techniques with an emphasis on antimycosal drug resistance for the treatment and management of mycosis DOI Creative Commons
Riya Sarkar, Krishnendu Adhikary,

Arundhati Banerjee

и другие.

Heliyon, Год журнала: 2024, Номер 10(16), С. e35835 - e35835

Опубликована: Авг. 1, 2024

Highlights•Antifungal drugs and their resistance development mechanism in mycosis infection.•Different metabolic path for potential targets of antifungal drugs.•The elevated risk factors, diagnosis management mycosis.•Complications assessing treatment strategies mycosis.•Updated immune therapeutics mycosis.AbstractInfections due to pathogenic fungi are endemic particular area with increased morbidity mortality. More than a thousand people infected per year the way is high demand having significant impact on population health. Medical practitioners confront various troublesome analytic therapeutical challenges administration immunosuppressed sufferer at danger expanding fungal infections. An upgraded antimycosal fundamental fruitful result while treating intrusive mycoses. A collection keeps developing specific including cell membrane, mitochondria, wall, deoxyribonucleic acid (DNA)/ribonucleic (RNA) or protein biosynthesis. Some classes ordinarily directed medications polyenes, amphotericin B, syringomycin, allylamines, honokiol, azoles, flucytosine, echinocandins etc. However, few immunotherapy processes vaccinations being developed mark this need, although one presently can't seem arrive conclusion. In review article, there has been trial give details upgradation about current therapeutic techniques vaccination against prevention as well difficulties related turn events. There also visualization mentioned paper assorted target analysis along interventions.Graphical abstractGraphical representation immunotherapeutic methods mycosis.

Язык: Английский

Процитировано

2

Impact of inorganic/organic nanomaterials on the immune system for disease treatment DOI
Jing Han,

Kuirong Mao,

Yong‐Guang Yang

и другие.

Biomaterials Science, Год журнала: 2024, Номер 12(19), С. 4903 - 4926

Опубликована: Янв. 1, 2024

Nanoparticles have been widely developed for immune regulation. This review summarizes the effects of inorganic/organic nanoparticles, and composite nanoparticles on system diseases.

Язык: Английский

Процитировано

1